Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Motor Activity 3Breast Neoplasms 3Pancreatic Neoplasms 2Multiple Myeloma 2Colorectal Neoplasms 2Smoldering Multiple Myeloma 1Skin Neoplasms 1Sarcopenia 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasms 1Melanoma 1Lymphedema 1Lung Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Bevacizumab 77Fluorouracil 55Cetuximab 48Oxaliplatin 43Leucovorin 42pembrolizumab 37Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 19trifluridine tipiracil drug combination 17Panitumumab 15Blood Specimen Collection 15Nivolumab 14Magnetic Resonance Spectroscopy 14regorafenib 13Biopsy 13Trifluridine 12Gemcitabine 12Cisplatin 12Standard of Care 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 10Cyclophosphamide 9tislelizumab 8Trastuzumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Resistance Training × Clear all
NCT06202183 2025-08-15

Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial

Dana-Farber Cancer Institute

Phase NA Recruiting
84 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06420726 2024-05-21

Resistance Exercise and Creatine in Colorectal Cancer

University of South Carolina

Phase NA Recruiting
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡